Biosimilars

All the posts published.

A Comparison of Proposed INESSS and Current CADTH Evaluation Fees

March 6, 2018

-

Market Access News

-

Posted by MORSE Team

Read More →

Upcoming Market Access Events / Conferences – September 2017

August 30, 2017

-

Market Access News

-

Posted by MORSE Team

Read More →

Biosimilar Panel – CAHR Market Access 201: Parallel or Intersecting Paths – Future of Public and Private Reimbursement in Canada

August 8, 2017

-

Market Access News, Publications

-

Posted by MORSE Team

Read More →

New Drug Submission Guidelines in Quebec

June 8, 2017

-

Market Access News

-

Posted by MORSE Team

Read More →

Canada Attempts Biosimilar Balancing Act

March 2, 2017

-

-

Posted by MORSE Team

Read More →

MORSE Perspective on pCPA Update as of December 31 2016

February 3, 2017

-

Market Access News

-

Posted by MORSE Team

Read More →

MORSE Consulting Inc.

Toronto | Ottawa, Canada

+1-647-717-3179 (Toronto)

+1-613-864-8645 (Ottawa)

info@morseconsulting.ca

MORSE Consulting Inc. | Deciphering Canadian pharmaceutical market access signals to create reimbursement success.

© 2021 MORSE Consulting Inc. All rights reserved. | Site by Directica Media

Biosimilars - Info and details on - Page 3 of 3 - MORSE Consulting Inc.